Illumina NovaSeq 6000 S4 Reagent Kits
Key Dates
Due Date
-
Posted Date
-
Agency & Value
Agency
NAVAL MEDICAL RESEARCH CENTER
Contract Value
Not provided
Codes & Classification
Solicitation Number
1301434156
NAICS
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Classification Code
6640
Additional Details
The United States Department of Navy Medicine Research and Development Command (NMRDC), operating under the Department of Defense and the Department of the Navy, has issued a Special Notice regarding its intent to award a sole source contract to Illumina Inc., based in San Diego, California. This procurement is for Illumina NovaSeq 6000 S4 Reagent Kits, which are essential consumables for high-throughput sequencing operations. The place of performance for this requirement is Frederick, Maryland.
The primary objective of this procurement is to secure proprietary reagent kits that are specifically designed for use with the Illumina NovaSeq 6000 sequencing platform. These kits are critical for ongoing research and development activities in biotechnology, as classified under NAICS code 541714 (Research and Development in Biotechnology, except Nanobiotechnology). The procurement falls under Product Service Code 6640, which covers laboratory equipment and supplies.
This action will be conducted in accordance with FAR Part 12, which governs the acquisition of commercial items. The notice explicitly states that Illumina does not authorize third-party vendors for these products, underscoring the proprietary nature of the reagents and the necessity for a sole source award. While this is not a request for competitive proposals, the government will consider all responses received.
Contractors interested in this opportunity must be registered in the System for Award Management (SAM) and possess a Unique Entity Identification Number (UEI). Registration in SAM is a prerequisite for award eligibility, and additional information can be found at www.sam.gov or by contacting their helpdesk.
The contracting entity for this procurement is the Naval Medical Research Center, a federal office within the Department of the Navy. The primary point of contact for this notice is Shamai Carter ([email protected]), with secondary contact Nataki Johnson ([email protected], 301-319-7303) available for further inquiries.
The notice was posted on November 13, 2026, with a response deadline of November 20, 2026. The opportunity remains active and is accessible via the SAM.gov portal at the provided URL.
In summary, this procurement seeks to ensure the uninterrupted supply of Illumina NovaSeq 6000 S4 Reagent Kits for critical biotechnology research at the Naval Medical Research Center. The sole source nature of the award, the requirement for SAM registration, and the proprietary status of the reagents are key considerations for any potential respondents evaluating their eligibility and interest in this opportunity.